Guarantees (Details) (USD $) In Millions, unless otherwise specified	Apr. 30, 2004 Pharmacopeia Drug Discovery, Inc.	Dec. 31, 2013 Lease Guarantee	Dec. 31, 2012 Lease Guarantee
Guarantor Obligations [Line Items]
Stock split conversion ratio	0.5
Guarantee of remaining lease obligations		$ 6.2
Irrevocable letter of credit		$ 0.1	$ 0.2

Stockholders Equity Note Reverse Stock Split Conversion Ratio

No definition available.

Name:	accl_StockholdersEquityNoteReverseStockSplitConversionRatio
Namespace Prefix:	accl_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	instant

- Definition

The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 4

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248

+ Details

Name:	us-gaap_GuaranteeObligationsCurrentCarryingValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_GuaranteeObligationsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 4

-Subparagraph (b)(1)

-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248

+ Details

Name:	us-gaap_GuaranteeObligationsMaximumExposure
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant